TScan Therapeutics, Inc. (TCRX)
1.015
-0.06
(-5.14%)
USD |
NASDAQ |
Dec 12, 16:00
1.015
0.00 (0.00%)
After-Hours: 16:11
TScan Therapeutics Shareholders Equity (Quarterly): 144.02M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Geron Corp. | 248.71M |
| Novavax, Inc. | -156.67M |
| XOMA Royalty Corp. | 107.96M |
| SELLAS Life Sciences Group, Inc. | 45.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 262.22M |
| Total Liabilities (Quarterly) | 118.20M |
| Debt to Equity Ratio | 0.6639 |
| Current Ratio | 6.442 |
| Net Debt Paydown Yield | -0.88% |